Advertisement
Clinical studies| Volume 109, ISSUE 1, P1-8, July 28, 2000

Proteinuria as a risk factor for cardiovascular disease and mortality in older people: a prospective study

  • Bruce F Culleton
    Affiliations
    National Heart, Lung, and Blood Institute’s Framingham Heart Study (BFC, MGL, WBK, DL), Framingham, Massachusetts, USA
    Search for articles by this author
  • Martin G Larson
    Affiliations
    National Heart, Lung, and Blood Institute’s Framingham Heart Study (BFC, MGL, WBK, DL), Framingham, Massachusetts, USA

    Department of Preventive Medicine and Epidemiology (MGL, WBK, DL), Boston University School of Medicine, Boston, Massachusetts, USA
    Search for articles by this author
  • Patrick S Parfrey
    Affiliations
    Division of Nephrology (PSP), Memorial University of Newfoundland, St. John’s, Newfoundland, Canada
    Search for articles by this author
  • William B Kannel
    Affiliations
    National Heart, Lung, and Blood Institute’s Framingham Heart Study (BFC, MGL, WBK, DL), Framingham, Massachusetts, USA

    Department of Preventive Medicine and Epidemiology (MGL, WBK, DL), Boston University School of Medicine, Boston, Massachusetts, USA
    Search for articles by this author
  • Daniel Levy
    Correspondence
    Requests for reprints should be addressed to Daniel Levy, MD, Framingham Heart Study, 5 Thurber Street, Framingham, Massachusetts 01702
    Affiliations
    National Heart, Lung, and Blood Institute’s Framingham Heart Study (BFC, MGL, WBK, DL), Framingham, Massachusetts, USA

    Department of Preventive Medicine and Epidemiology (MGL, WBK, DL), Boston University School of Medicine, Boston, Massachusetts, USA
    Search for articles by this author

      Abstract

      BACKGROUND: The prognostic significance of proteinuria in older people is not well defined. We examined the associations between proteinuria and incident coronary heart disease, cardiovascular mortality, and all-cause mortality in older people.
      SUBJECTS AND METHODS: Casual dipstick proteinuria was determined in 1,045 men (mean [± SD] age 68 ± 7 years) and 1,541 women (mean age 69 ± 7 years) attending the 15th biennial examination of the Framingham Heart Study. Participants were divided by grade of proteinuria: none (85.3%), trace (10.2%), and greater-than-trace (4.5%). Cox proportional hazards analyses were used to determine the relations of baseline proteinuria to the specified outcomes, adjusting for other risk factors, including serum creatinine level.
      RESULTS: During 17 years of follow-up, there were 455 coronary heart disease events, 412 cardiovascular disease deaths, and 1,214 deaths. In men, baseline proteinuria was associated with all-cause mortality (hazards ratio [HR] = 1.3, 95% confidence interval [CI] 1.0 to 1.7 for trace proteinuria; HR = 1.3, 95% CI 1.0 to 1.8 for greater-than-trace proteinuria; P for trend = 0.02). In women, trace proteinuria was associated with cardiovascular disease death (HR = 1.6, 95% CI 1.1 to 2.4), and all-cause mortality (HR = 1.4, 95% CI 1.1 to 1.7).
      CONCLUSION: Proteinuria is a significant, although relatively weak, risk factor for all-cause mortality in men and women, and for cardiovascular disease mortality in women.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to The American Journal of Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Ruggenenti P
        • Perna A
        • Mosconi L
        • et al.
        Urinary protein excretion rate is the best independent predictor of ESRF in non-diabetic proteinuric chronic nephropathies. “Gruppo Italiano di Studi Epidemiologici in Nefrologia” (GISEN).
        Kidney Int. 1998; 53: 1209-1216
        • Abbott K.C
        • Sanders L.R
        • Bakris G.L
        Microalbuminuria in non-insulin-dependent diabetes mellitus. Implications for renal survival.
        Arch Intern Med. 1994; 154: 146-153
        • Miettinen H
        • Haffner S.M
        • Lehto S
        • et al.
        Proteinuria predicts stroke and other atherosclerotic vascular disease events in nondiabetic and non-insulin-dependent diabetic subjects.
        Stroke. 1996; 27: 2033-2039
        • Wagner D.K
        • Harris T
        • Madans J.H
        Proteinuria as a biomarker.
        Environ Res. 1994; 66: 160-172
        • Samuelsson O
        • Wilhelmsen L
        • Elmfeldt D
        • et al.
        Predictors of cardiovascular morbidity in treated hypertension.
        J Hypertens. 1985; 3: 167-176
        • Ljungman S
        • Wikstrand J
        • Hartford M
        • Berglund G
        Urinary albumin excretion—a predictor of risk of cardiovascular disease. A prospective 10-year follow-up of middle-aged nondiabetic normal and hypertensive men.
        Am J Hypertens. 1996; 9: 770-778
        • Morrish N.J
        • Stevens L.K
        • Fuller J.H
        • et al.
        Risk factors for macrovascular disease in diabetes mellitus.
        Diabetologia. 1991; 34: 590-594
        • Messent J.W
        • Elliott T.G
        • Hill R.D
        • et al.
        Prognostic significance of microalbuminuria in insulin-dependent diabetes mellitus.
        Kidney Int. 1992; 41: 836-839
        • Schmitz A
        • Vaeth M
        Microalbuminuria.
        Diabet Med. 1988; 5: 126-134
        • Gall M.A
        • Borch-Johnsen K
        • Hougaard P
        • et al.
        Albuminuria and poor glycemic control predict mortality in NIDDM.
        Diabetes. 1995; 44: 1303-1309
        • Agewall S
        • Wikstrand J
        • Ljungman S
        • Fagerberg B
        Usefulness of microalbuminuria in predicting cardiovascular mortality in treated hypertensive men with and without diabetes mellitus. Risk factor intervention study group.
        Am J Cardiol. 1997; 80: 164-169
        • Grimm Jr, R.H
        • Svendsen K.H
        • Kasiske B
        • et al.
        Proteinuria is a risk factor for mortality over 10 years of follow-up.
        Kidney Int. 1997; 52: 10-14
        • Kannel W.B
        • Stampfer M.J
        • Castelli W.P
        • Verter J
        The prognostic significance of proteinuria.
        Am Heart J. 1984; 108: 1347-1352
        • Casiglia E
        • Pauletto P
        • Mazza A
        • et al.
        Impaired glucose tolerance and its co-variates among 2079 non-diabetic elderly subjects. Ten-year mortality and morbidity in the CASTEL study.
        Acta Diabetol. 1996; 33: 284-290
        • Stephenson J.M
        • Kenny S
        • Stevens L.K
        • et al.
        Proteinuria and mortality in diabetes.
        Diabet Med. 1995; 12: 149-155
        • Mattock M.B
        • Morrish N.J
        • Viberti G
        • et al.
        Prospective study of microalbuminuria as predictor of mortality in NIDDM.
        Diabetes. 1992; 41: 736-741
        • Damsgaard E.M
        • Froland A
        • Jorgensen O.D
        • Mogensen C.E
        Eight to nine year mortality in known non-insulin dependent diabetics and controls.
        Kidney Int. 1992; 41: 731-735
        • Mogensen C.E
        Microalbuminuria predicts clinical proteinuria and early mortality in maturity-onset diabetes.
        NEJM. 1984; 310: 356-360
        • Nelson R.G
        • Pettitt D.J
        • Carraher M.J
        • et al.
        Effect of proteinuria on mortality in NIDDM.
        Diabetes. 1988; 37: 1499-1504
        • Jarrett R.J
        • Viberti G.C
        • Argyropoulos A
        • et al.
        Microalbuminuria predicts mortality in non-insulin-dependent diabetics.
        Diabet Med. 1984; 1: 17-19
        • Neil A
        • Hawkins M
        • Potok M
        • et al.
        A prospective population-based study of microalbuminuria as a predictor of mortality in NIDDM.
        Diabetes Care. 1993; 16: 996-1003
        • Bulpitt C.J
        • Beilin L.J
        • Clifton P
        • et al.
        Risk factors for death in treated hypertensive patients. Report from the D.H.S.S. Hypertension Care Computing Project.
        Lancet. 1979; 2: 134-137
        • Damsgaard E.M
        • Froland A
        • Jorgensen O.D
        • Mogensen C.E
        Microalbuminuria as predictor of increased mortality in elderly people.
        BMJ. 1990; 300: 297-300
        • Deckert T
        • Feldt-Rasmussen B
        • Borch-Johnsen K
        • et al.
        Albuminuria reflects widespread vascular damage. The Steno hypothesis.
        Diabetologia. 1989; 32: 219-226
        • Bianchi S
        • Bigazzi R
        • Valtriani C
        • et al.
        Elevated serum insulin levels in patients with essential hypertension and microalbuminuria.
        Hypertension. 1994; 23: 681-687
        • Haffner S.M
        • Stern M.P
        • Gruber M.K
        • et al.
        Microalbuminuria. Potential marker for increased cardiovascular risk factors in nondiabetic subjects?.
        Arteriosclerosis. 1990; 10: 727-731
        • Groop L
        • Ekstrand A
        • Forsblom C
        • et al.
        Insulin resistance, hypertension and microalbuminuria in patients with type 2 (non-insulin-dependent) diabetes mellitus.
        Diabetologia. 1993; 36: 642-647
        • Woo J
        • Cockram C.S
        • Swaminathan R
        • et al.
        Microalbuminuria and other cardiovascular risk factors in nondiabetic subjects.
        Int J Cardiol. 1992; 37: 345-350
        • Mykkanen L
        • Zaccaro D.J
        • Wagenknecht L.E
        • et al.
        Microalbuminuria is associated with insulin resistance in nondiabetic subjects.
        Diabetes. 1998; 47: 793-800
        • Hoogeveen E.K
        • Kostense P.J
        • Jager A
        • et al.
        Serum homocysteine level and protein intake are related to risk of microalbuminuria.
        Kidney Int. 1998; 54: 203-209
        • Chico A
        • Perez A
        • Cordoba A
        • et al.
        Plasma homocysteine is related to albumin excretion rate in patients with diabetes mellitus.
        Diabetologia. 1998; 41: 684-693
        • Bigazzi R
        • Bianchi S
        • Nenci R
        • et al.
        Increased thickness of the carotid artery in patients with essential hypertension and microalbuminuria.
        J Hum Hypertens. 1995; 9: 827-833
        • Knobl P
        • Schernthaner G
        • Schnack C
        • et al.
        Thrombogenic factors are related to urinary albumin excretion rate in type 1 (insulin-dependent) and type 2 (non-insulin-dependent) diabetic patients.
        Diabetologia. 1993; 36: 1045-1050
        • Harris T
        • Cook E.F
        • Kannel W.B
        • Goldman L
        Proportional hazards analysis of risk factors for coronary heart disease in individuals aged 65 or older.
        J Am Geriatr Soc. 1988; 36: 1023-1028
        • Dawber T.R
        • Meadors G.F
        • Moore F.E
        Epidemiologic approaches to heart disease.
        Am J Public Health. 1951; 41: 279-286
      1. The sixth report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Arch Intern Med. 1997;157:2413–2446.

        • Abell L.L
        • Levy B.B
        • Brodie B.B
        • Kendall F.E
        A simplified method for the estimation of total cholesterol in serum and demonstration of its specificity.
        J Biol Chem. 1952; 195: 357-366
      2. Shurtleff D. Some characteristics related to the incidence of cardiovascular disease and death: Framingham Heart Study 18-year follow-up. In: Kannel WB, Gordon T, eds. The Framingham Study, Section 30. Washington, DC: US Government Printing Office; 1974:7–25.

        • Cox D.R
        Regression models and life tables.
        J Roy Stat Soc. 1972; 34: 187-220
      3. SAS/STAT User’s Guide, Version 6. SAS Institute, Cary, NC1989
        • Yudkin J.S
        • Forrest R.D
        • Jackson C.A
        Microalbuminuria as predictor of vascular disease in non-diabetic subjects.
        Lancet. 1988; 2: 530-533
        • Damsgaard E.M
        • Froland A
        • Jorgensen O.D
        • Morgensen C.E
        Prognostic value of urinary albumin excretion rate and other risk factors in elderly diabetic patients and non-diabetic control subjects surviving the first 5 years after assessment.
        Diabetologia. 1993; 36: 1030-1036
        • Bigazzi R
        • Bianchi S
        • Baldari D
        • Campese V.M
        Microalbuminuria predicts cardiovascular events and renal insufficiency in patients with essential hypertension.
        J Hypertens. 1998; 16: 1325-1333
        • Stehouwer C.D
        • Nauta J.J
        • Zeldenrust G.C
        • et al.
        Urinary albumin excretion, cardiovascular disease, and endothelial dysfunction in non-insulin-dependent diabetes mellitus.
        Lancet. 1992; 340: 319-323
        • Jensen J.S
        • Borch-Johnsen K
        • Jensen G
        • Feldt-Rasmussen B
        Microalbuminuria reflects a generalized transvascular albumin leakiness in clinically healthy subjects.
        Clin Sci (Colch). 1995; 88: 629-633
        • Pedrinelli R
        • Giampietro O
        • Carmassi F
        • et al.
        Microalbuminuria and endothelial dysfunction in essential hypertension.
        Lancet. 1994; 344: 14-18
        • Fleck A
        • Raines G
        • Hawker F
        • et al.
        Increased vascular permeability.
        Lancet. 1985; 1: 781-784
        • Nelson R.G
        • Knowler W.C
        • Pettitt D.J
        • et al.
        Diabetic kidney disease in Pima Indians.
        Diabetes Care. 1993; 16: 335-341
        • Brancati F.L
        • Whittle J.C
        • Whelton P.K
        • et al.
        The excess incidence of diabetic end-stage renal disease among blacks. A population-based study of potential explanatory factors.
        JAMA. 1992; 268: 3079-3084
        • Smith S.R
        • Svetkey L.P
        • Dennis V.W
        Racial differences in the incidence and progression of renal diseases.
        Kidney Int. 1991; 40: 815-822
        • Whittle J.C
        • Whelton P.K
        • Seidler A.J
        • Klag M.J
        Does racial variation in risk factors explain black-white differences in the incidence of hypertensive end-stage renal disease?.
        Arch Intern Med. 1991; 151: 1359-1364
        • Schwab S.J
        • Dunn F.L
        • Feinglos M.N
        Screening for microalbuminuria. A comparison of single sample methods of collection and techniques of albumin analysis.
        Diabetes Care. 1992; 15: 1581-1584
        • Robinson R.R
        Isolated proteinuria in asymptomatic patients.
        Kidney Int. 1980; 18: 395-406
        • Poortmans J.R
        Postexercise proteinuria in humans. Facts and mechanisms.
        JAMA. 1985; 253: 236-240
        • Poortmans J.R
        • Brauman H
        • Staroukine M
        • et al.
        Indirect evidence of glomerular/tubular mixed-type postexercise proteinuria in healthy humans.
        Am J Physiol. 1988; 254: 277-283
        • Carrie B.J
        • Hilberman M
        • Schroeder J.S
        • Myers B.D
        Albuminuria and the permselective properties of the glomerulus in cardiac failure.
        Kidney Int. 1980; 17: 507-514
        • Rytand D.A
        • Spreiter S
        Prognosis in postural (orthostatic) proteinuria.
        NEJM. 1981; 305: 618-621